Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

747 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation.
Ishikawa J, Maeda T, Kashiwagi H, Yoshida H, Takahashi I, Kawamoto SI, Yamada M, Kato H, Nishiura T, Tomiyama Y, Matsuzawa Y. Ishikawa J, et al. Bone Marrow Transplant. 2003 Jun;31(11):1057-9. doi: 10.1038/sj.bmt.1704059. Bone Marrow Transplant. 2003. PMID: 12774060
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
Yagi T, Ishikawa J, Aono N, Yamashita Y, Kusakabe S, Yoshinami T, Akazawa Y, Sakai D, Yamamoto S, Hamanaka Y, Masaie H, Sugimoto N, Yoshida H, Tomita Y, Imamura F. Yagi T, et al. Among authors: ishikawa j. Int J Hematol. 2012 Feb;95(2):214-6. doi: 10.1007/s12185-011-0979-4. Epub 2011 Dec 16. Int J Hematol. 2012. PMID: 22170229
Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
Kawamoto S, Oritani K, Asada H, Takahashi I, Ishikawa J, Yoshida H, Yamada M, Ishida N, Ujiie H, Masaie H, Tomiyama Y, Matsuzawa Y. Kawamoto S, et al. Among authors: ishikawa j. J Virol. 2003 Sep;77(17):9622-31. doi: 10.1128/jvi.77.17.9622-9631.2003. J Virol. 2003. PMID: 12915574 Free PMC article.
A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-alpha.
Kawamoto S, Oritani K, Asakura E, Ishikawa J, Koyama M, Miyano K, Iwamoto M, Yasuda S, Nakakubo H, Hirayama F, Ishida N, Ujiie H, Masaie H, Tomiyama Y. Kawamoto S, et al. Among authors: ishikawa j. Exp Hematol. 2004 Sep;32(9):797-805. doi: 10.1016/j.exphem.2004.06.008. Exp Hematol. 2004. PMID: 15345280 Free article.
747 results